Rhein: A potential biological therapeutic drug for intervertebral disc degeneration

Medical Hypotheses

Volumn 77, Issue 6, 2011, Pages 1105-1107

  Li, Hao ^a   Liang, Chengzhen ^a   Chen, Qixin ^a   Yang, Zhengming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS1 PROTEIN; AGGRECANASE 1; AGGRECANASE 2; INTERLEUKIN 1; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; RHEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BIOSYNTHESIS; CARTILAGE DEGENERATION; CATABOLISM; DRUG ACTIVITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HOMEOSTASIS; INTERVERTEBRAL DISK DEGENERATION; NONHUMAN; OSTEOARTHRITIS; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ANTHRAQUINONES; APOPTOSIS; ENDOPEPTIDASES; HUMANS; INTERLEUKIN-1; INTERVERTEBRAL DISC DEGENERATION; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL;

EID: 80755153571     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.09.013     Document Type: Article

References (40)

1. Freemont A.J. The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxf) 2009, 48:5-10.
2. Becker A., Held H., Redaelli M., Strauch K., Chenot J.F., Leonhardt C., et al. Low back pain in primary care: costs of care and prediction of future health care utilization. Spine (Phila Pa 1976) 2010, 35:1714-1720.
3. Martin B.I., Deyo R.A., Mirza S.K., Turner J.A., Comstock B.A., Hollingworth W., et al. Expenditures and health status among adults with back and neck problems. JAMA 2008, 299:656-664.
4. Wang Y.X., Griffith J.F. Menopause causes vertebral endplate degeneration and decrease in nutrient diffusion to the intervertebral discs. Med Hypotheses 2011, 77:18-20.
5. Smith L.J., Nerurkar N.L., Choi K.S., Harfe B.D., Elliott D.M. Degeneration and regeneration of the intervertebral disc: lessons from development. Dis Model Mech 2011, 4:31-41.
6. Adams M.A., Stefanakis M., Dolan P. Healing of a painful intervertebral disc should not be confused with reversing disc degeneration: implications for physical therapies for discogenic back pain. Clin Biomech (Bristol, Avon) 2010, 25:961-971.
7. Le Maitre C.L., Freemont A.J., Hoyland J.A. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005, 7:R732-745.
8. Ulrich J.A., Liebenberg E.C., Thuillier D.U., Lotz J.C. ISSLS prize winner: repeated disc injury causes persistent inflammation. Spine (Phila Pa 1976) 2007, 32:2812-2819.
9. Goupille P., Mulleman D., Chevalier X. Is interleukin-1 a good target for therapeutic intervention in intervertebral disc degeneration: lessons from the osteoarthritic experience. Arthritis Res Ther 2007, 9:110.
10. Hao Y.D., Yu G.R., Liu Y.P. Another possible mechanism for orally administered statins retarding the pathologic process of disc degeneration. Med Hypotheses 2011, 76:302-303.
11. Zhao J.G., Wang J., Xin Q., Zhang P., Zhang S.F., Qi F., et al. Calcium pentosan polysulfate and sodium pentosan polysulfate may be used to treat intervertebral disc degeneration. Med Hypotheses 2011, 76:610-613.
12. Smith V.H. Vitamin C deficiency is an under-diagnosed contributor to degenerative disc disease in the elderly. Med Hypotheses 2010, 74:695-697.
13. He Z.H., Zhou R., He M.F., Lau C.B., Yue G.G., Ge W., et al. Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei. Phytomedicine 2011, 18:470-478.
14. Chen Y.Y., Chiang S.Y., Lin J.G., Ma Y.S., Liao C.L., Weng S.W., et al. Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Int J Oncol 2010, 36:1113-1120.
15. Gao Q., Qin W.S., Jia Z.H., Zheng J.M., Zeng C.H., Li L.S., et al. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med 2010, 76:27-33.
16. Brahmachari B., Chatterjee S., Ghosh A. Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trial. Clin Rheumatol 2009, 28:1193-1198.
17. Legendre F., Heuze A., Boukerrouche K., Leclercq S., Boumediene K., Galera P., et al. Rhein, the metabolite of diacerhein, reduces the proliferation of osteoarthritic chondrocytes and synoviocytes without inducing apoptosis. Scand J Rheumatol 2009, 38:104-111.
18. Martin G., Bogdanowicz P., Domagala F., Ficheux H., Pujol J.P. Rhein inhibits interleukin-1 beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappa B and AP-1 in chondrocytes cultured in hypoxia: a potential mechanism for its disease-modifying effect in osteoarthritis. Inflammation 2003, 27:233-246.
19. Domagala F., Martin G., Bogdanowicz P., Ficheux H., Pujol J.P. Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for diacerein effects in osteoarthritis. Biorheology 2006, 43:577-587.
20. Deffaud J., Kirchmeyer M., Domagala F., Ficheux H., Netter P., Bianchi A., et al. Modulatory effect of rhein on IL-1alpha-induced responses in human chondrocytes: a comparative study between antibody microarrays and specific ELISAs. Biorheology 2008, 45:439-455.
21. Bartels E.M., Bliddal H., Schondorff P.K., Altman R.D., Zhang W., Christensen R. Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage 2010, 18:289-296.
22. Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne R., Rorabeck C., et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997, 99:1534-1545.
23. Carroll G.J. Precocious bilateral hip joint osteoarthritis is a "form-fruste" of the arthropathy of hereditary haemochromatosis. Med Hypotheses 2010, 74:719-721.
24. Shlopov B.V., Lie W.R., Mainardi C.L., Cole A.A., Chubinskaya S., Hasty K.A. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997, 40:2065-2074.
25. Wassilew G.I., Lehnigk U., Duda G.N., Taylor W.R., Matziolis G., Dynybil C. The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders. Arthroscopy 2010, 26:1096-1104.
26. Kronheim S.R., Mumma A., Greenstreet T., Glackin P.J., Van Ness K., March C.J., et al. Purification of interleukin-1 beta converting enzyme, the protease that cleaves the interleukin-1 beta precursor. Arch Biochem Biophys 1992, 296:698-703.
27. Mohammadi A., Rezanour N., Ansari Dogaheh M., Ghorbani Bidkorbeh F., Hashem M., Walker R.B. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 846:215-221.
28. Pujol J.P., Chadjichristos C., Legendre F., Bauge C., Beauchef G., Andriamanalijaona R., et al. Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res 2008, 49:293-297.
29. Li X., Phillips F.M., An H.S., Ellman M., Thonar E.J., Wu W., et al. The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc. Spine (Phila Pa 1976) 2008, 33:2586-2595.
30. Masuda K., An H.S. Growth factors and the intervertebral disc. Spine J 2004, 4:330S-340S.
31. Masuda K., Oegema T.R., An H.S. Growth factors and treatment of intervertebral disc degeneration. Spine (Phila Pa 1976) 2004, 29:2757-2769.
32. Goupille P., Jayson M.I., Valat J.P., Freemont A.J. Matrix metalloproteinases: the clue to intervertebral disc degeneration?. Spine (Phila Pa 1976) 1998, 23:1612-1626.
33. Maeda S., Kokubun S. Changes with age in proteoglycan synthesis in cells cultured in vitro from the inner and outer rabbit annulus fibrosus. Responses to interleukin-1 and interleukin-1 receptor antagonist protein. Spine (Phila Pa 1976) 2000, 25:166-169.
34. Koch H., Reinecke J.A., Meijer H., Wehling P. Spontaneous secretion of interleukin 1 receptor antagonist (IL-1ra) by cells isolated from herniated lumbar discal tissue after discectomy. Cytokine 1998, 10:703-705.
35. Zhao C.Q., Liu D., Li H., Jiang L.S., Dai L.Y. Interleukin-1beta enhances the effect of serum deprivation on rat annular cell apoptosis. Apoptosis 2007, 12:2155-2161.
36. Rastogi A., Thakore P., Leung A., Benavides M., Machado M., Morschauser M.A., et al. Environmental regulation of notochordal gene expression in nucleus pulposus cells. J Cell Physiol 2009, 220:698-705.
37. Han B., Zhu K., Li F.C., Xiao Y.X., Feng J., Shi Z.L., et al. A simple disc degeneration model induced by percutaneous needle puncture in the rat tail. Spine (Phila Pa 1976) 2008, 33:1925-1934.
38. Cui Y., Yu J., Urban J.P., Young D.A. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes. Spine (Phila Pa 1976) 2010, 35:1101-1108.
39. Sawaji Y., Hynes J., Vincent T., Saklatvala J. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum 2008, 58:3498-3509.
40. Niu C.C., Yuan L.J., Chen L.H., Lin S.S., Tsai T.T., Liao J.C., et al. Beneficial effects of hyperbaric oxygen on human degenerated intervertebral disk cells via suppression of IL-1beta and p38 MAPK signal. J Orthop Res 2011, 29:14-19.